Dr Nisar Ahmed Ph.D NeuroVascular Specialist

Dr Nisar Ahmed Ph.D NeuroVascular Specialist we deal with neuro cases (CP child, DMD, leukodystrophy paralysis, genetic and auto immune diseases with Bio regulatory medicine
(3)

IntroductionDiabetes mellitus is a group of chronic metabolic disorders characterized by persistent or recurrent hypergl...
10/08/2026

Introduction

Diabetes mellitus is a group of chronic metabolic disorders characterized by persistent or recurrent hyperglycemia resulting from abnormalities in insulin secretion, insulin action, or both. Although elevated blood glucose is its most recognizable biochemical feature, diabetes is considerably broader than a disorder of glucose concentration alone.

The diabetic state involves disturbances in:

- glucose uptake and utilization,
- hepatic glucose production,
- glycogen synthesis and breakdown,
- lipid storage and mobilization,
- fatty-acid oxidation,
- amino-acid metabolism,
- pancreatic β-cell function,
- mitochondrial energy metabolism,
- vascular biology,
- renal handling of nutrients,
- inflammatory signaling,
- oxidative stress,
- and hormonal regulation of metabolic flexibility.

From established biomedical science, diabetes therefore represents a disorder of integrated metabolic regulation.

Within CHON Balancing Mitotherapy (CBM), diabetes may additionally be interpreted through the proposed relationships among carbon (C), hydrogen (H), oxygen (O), and nitrogen (N), together with the CBM NH↔OC Energy Toggle.

These CBM concepts constitute an interpretive framework and should not be confused with established biochemical nomenclature, diagnostic criteria, or validated mechanisms of diabetes.

The purpose of this chapter is therefore twofold:

1. to describe the recognized physiology and pathophysiology of diabetes mellitus; and
2. to explore how these processes may be conceptually represented within the CBM framework.

The guiding principle remains:

CBM stands beside biology—not against it.

10/08/2026

Abdullah mayopathy patient improved with CHON BALANCING MITOTHERAPY

Obesity and insulin resistance are closely interconnected metabolic states involving disturbances in energy storage, nut...
09/08/2026

Obesity and insulin resistance are closely interconnected metabolic states involving disturbances in energy storage, nutrient utilization, hormonal signaling, adipose-tissue biology, inflammation, mitochondrial function, and metabolic flexibility.

In conventional metabolic science, obesity is not simply the presence of excessive body weight. It is characterized by excessive or dysfunctional adipose-tissue accumulation that may adversely affect health. Likewise, insulin resistance is not merely an excess or deficiency of insulin. It describes a state in which insulin-responsive tissues—particularly skeletal muscle, liver, and adipose tissue—show reduced biological responsiveness to normal concentrations of insulin.

09/08/2026

Down syndrome Mannaz zehra of Ali pur Islamabad improved with CHON BALANCING MITOTHERAPY Dr Nisar Ahmed gorar

Chapter 21 — CBM Interpretation of Obesity and Insulin ResistanceAnalysis of excessive nutrient storage, impaired metabo...
07/08/2026

Chapter 21 — CBM Interpretation of Obesity and Insulin Resistance

Analysis of excessive nutrient storage, impaired metabolic flexibility, hyperinsulinemia, adipose dysfunction, and possible CHON-pattern interpretations.

Chapter 22 — CBM Interpretation of Diabetes Mellitus

A structured interpretation of glucose dysregulation, insulin production, insulin resistance, hepatic metabolism, cellular energy utilization, and CHON balance.

Chapter 23 — CBM Interpretation of Polycystic O***y Syndrome

Integration of insulin resistance, reproductive endocrinology, androgen excess, adiposity, and proposed CHON metabolic patterns.

Chapter 24 — CBM Interpretation of Fatty Liver Disease

Interpretation of hepatic fat accumulation, lipogenesis, mitochondrial stress, insulin resistance, and metabolic imbalance through the CBM framework.

Chapter 25 — CBM Interpretation of Metabolic Syndrome

A unified discussion of obesity, insulin resistance, hypertension, dyslipidemia, fatty liver, and chronic metabolic inflammation.

Chapter 26 — Diet, Fasting, Exercise, and the mTOR–AMPK Axis

Effects of feeding, fasting, caloric restriction, carbohydrates, proteins, amino acids, resistance exercise, aerobic exercise, sleep, and circadian rhythms on metabolic signaling.

Chapter 27 — Clinical Assessment of Metabolic Disorders

Relevant investigations may include fasting blood glucose, HbA1c, fasting insulin, lipid profile, liver-function tests, renal-function tests, uric acid, electrolytes, blood pressure, body-mass index, waist circumference, and other clinically appropriate metabolic markers.

HOMA-IR may also be discussed as an indirect estimate of insulin resistance, with appropriate explanation of its limitations.

Chapter 28 — Clinical Case Interpretation in CBM

Structured case discussions involving obesity, insulin resistance, type 2 diabetes, PCOS, fatty liver disease, dyslipidemia, hyperuricemia, and metabolic syndrome.

Each case should clearly separate established clinical findings from proposed CBM interpretation.

Chapter 29 — Research Questions and Testable CBM Hypotheses

This chapter should define which CBM claims remain theoretical and how they could be tested scientifically.

Possible areas include correlations between proposed CHON patterns and measurable metabolic markers, hormonal profiles, mitochondrial function, inflammatory markers, insulin sensitivity, body composition, and clinical outcomes.

Chapter 30 — A Unified CBM Model of Metabolic Homeostasis

The final chapter should integrate cellular energy sensing, nutrient availability, insulin signaling, mTOR, AMPK, mitochondrial activity, autophagy, metabolic flexibility, and the proposed CHON regulatory framework into a single conceptual model.

Chapter 11 — Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatic insulin resistance, increased fatty-acid de...
07/08/2026

Chapter 11 — Metabolic Dysfunction-Associated Steatotic Liver Disease

Hepatic insulin resistance, increased fatty-acid delivery to the liver, de novo lipogenesis, triglyceride accumulation, oxidative stress, inflammation, and progression toward steatohepatitis and fibrosis.

Chapter 12 — Dyslipidemia and Lipid Metabolism

Triglycerides, LDL, HDL, lipoprotein metabolism, lipolysis, fatty-acid transport, beta-oxidation, hepatic lipid synthesis, and lipid-related cardiovascular risk.

Chapter 13 — Hyperuricemia, Uric Acid, and Gout

Purine metabolism, uric-acid production and excretion, fructose metabolism, insulin resistance, renal handling of uric acid, and associations with metabolic syndrome.

Chapter 14 — Hypertension and Metabolic Dysfunction

Insulin resistance, sympathetic nervous-system activity, endothelial dysfunction, renal sodium retention, vascular remodeling, obesity, and metabolic contributions to hypertension.

Chapter 15 — Mitochondrial Dysfunction in Metabolic Disease

Oxidative phosphorylation, ATP generation, mitochondrial biogenesis, reactive oxygen species, mitochondrial quality control, metabolic flexibility, and impaired mitochondrial function in chronic disease.

Chapter 16 — Metaflammation

Chronic low-grade metabolic inflammation, adipose-tissue macrophages, cytokines, NF-kappa B signaling, inflammatory mediators, and the relationship between inflammation and insulin resistance.

Chapter 17 — Autophagy, Nutrient Signaling, and Cellular Recycling

Autophagy as a cellular recycling mechanism, regulation by nutrient availability, inhibition by mTOR, activation during energy stress, and its role in cellular maintenance.

Chapter 18 — Aging, Metabolism, and the mTOR–AMPK Axis

Insulin/IGF signaling, mTOR activity, AMPK, autophagy, mitochondrial function, nutrient sensing, cellular senescence, and metabolic aspects of biological aging.

Chapter 19 — Cancer Metabolism and mTOR Signaling

Metabolic reprogramming in cancer, PI3K–AKT–mTOR signaling, altered glucose metabolism, the Warburg effect, nutrient utilization, growth signaling, and mitochondrial adaptation.

Cancer should not be described as merely a disease of excessive mTOR activity. It is biologically heterogeneous and involves genetic, epigenetic, signaling, metabolic, immune, and microenvironmental abnormalities.

Chapter 20 — The CBM NH↔OC Energy Toggle

Introduction of the CBM model of opposing metabolic tendencies.

The NH-oriented tendency may be explored in relation to anabolic activity, nutrient storage, biosynthesis, cellular growth, and restorative processes.

The OC-oriented tendency may be explored in relation to energy expenditure, mobilization, oxidative activity, catabolic processes, and metabolic adaptation.

This chapter should explicitly distinguish CBM interpretation from established biochemical terminology.

Chapter 1 — Foundations of Metabolism and Metabolic HomeostasisIntroduction to metabolism, anabolism, catabolism, ATP, g...
07/08/2026

Chapter 1 — Foundations of Metabolism and Metabolic Homeostasis

Introduction to metabolism, anabolism, catabolism, ATP, glucose metabolism, lipid metabolism, amino-acid metabolism, cellular energy balance, and metabolic homeostasis.

Chapter 2 — Cellular Energy Sensing

ATP, ADP, AMP, nutrient availability, cellular energy status, metabolic flexibility, and the mechanisms by which cells detect energy abundance or deficiency.

Chapter 3 — The mTOR Signaling System

Detailed study of mTORC1 and mTORC2, insulin signaling, IGF-1, amino-acid sensing, AKT signaling, protein synthesis, cell growth, lipid synthesis, and suppression of autophagy.

Chapter 4 — AMPK: The Cellular Energy Sensor

AMPK activation during low-energy states, AMP/ATP balance, glucose uptake, fatty-acid oxidation, mitochondrial regulation, inhibition of energy-consuming processes, and interaction with mTOR.

Chapter 5 — The mTOR–AMPK Metabolic Switch

The physiological balance between feeding and fasting, growth and repair, storage and utilization, anabolism and catabolism, and nutrient abundance versus cellular energy deficiency.

Chapter 6 — Insulin Biology and Insulin Resistance

Insulin receptor signaling, PI3K–AKT pathways, GLUT4 translocation, hepatic glucose production, hyperinsulinemia, impaired insulin signaling, and development of insulin resistance.

Chapter 7 — Obesity as a Metabolic Disorder

Adipose-tissue biology, adipocyte enlargement, adipokines, leptin, adiponectin, inflammation, ectopic fat deposition, mitochondrial dysfunction, and metabolic inflexibility.

Chapter 8 — Type 2 Diabetes Mellitus

Progression from insulin resistance to compensatory hyperinsulinemia, beta-cell stress, impaired glucose tolerance, beta-cell dysfunction, and chronic hyperglycemia.

Chapter 9 — Metabolic Syndrome

Central obesity, insulin resistance, hypertension, hypertriglyceridemia, low HDL cholesterol, chronic inflammation, and increased cardiovascular risk.

Chapter 10 — Polycystic O***y Syndrome as a Metabolic-Endocrine Disorder

Insulin resistance, hyperinsulinemia, androgen excess, ovarian dysfunction, altered follicular development, obesity, and the relationship between metabolic and reproductive abnormalities.

07/08/2026

Energy toggle is a switch between two metabolic modes depending on whether the body needs to store/build energy or release/use energy.

For example:

Fed state → storage mode
Glucose and nutrients are abundant → insulin rises → glycogen, fat, and protein synthesis increase.

Fasting/exercise → energy-use mode
Energy demand rises → stored fuels are mobilized → fatty acids and glucose are oxidized → mitochondria generate ATP.

In your CBM terminology, the proposed NH ↔ OC Energy Toggle means:

NH → building / storage / anabolic direction
↕ TOGGLE ↕
OC → mobilization / oxidation / catabolic energy direction

So, toggle simply means “switching back and forth.”

A useful sentence for the book would be:

“The NH–OC Energy Toggle is the proposed CBM term for the dynamic metabolic switching between energy storage and tissue-building states (NH direction) and fuel mobilization, oxidation, and ATP-generating states (OC direction).”

Importantly, “energy toggle” is CBM terminology, while the established biomedical concepts behind it include metabolic flexibility, insulin–glucagon regulation, AMPK/mTOR signaling, and fed–fasted metabolic switching.

07/08/2026

CHON Equilibrium and Biological Survival
Within the CHON Balancing Mitotherapy (CBM) framework, the four elemental pillars—Carbon (C), Hydrogen (H), Oxygen (O), and Nitrogen (N)—constitute the fundamental code of life. Maintaining the dynamic equilibrium among these elements is the core function of Homeostasis.
Pathophysiology as CHON Disturbance
When the internal balance among Carbon, Hydrogen, Oxygen, and Nitrogen is disrupted, the system experiences functional deviation.
* Pathology & Disease: A disturbance or strain in the CHON proportions represents the onset of disease. This triggers the innate Homeostatic Intelligence—acting as the Compliance Enforcement Unit—to initiate corrective metabolic and elemental adjustments (such as the Opposite Pair Law responses) to restore harmony.
* Compensated vs. Uncompensated States: Disease states reflect an ongoing, dynamic struggle by the biological system to buffer elemental excesses or deficiencies. While regulation is maintained, life persists under altered physiological states.
The Absolute Threshold of Life
The simultaneous presence of all four elemental vectors is non-negotiable for biological existence.
* The Code of Life: Carbon provides structure, Hydrogen supplies emotion and moisture, Oxygen drives energy and heat, and Nitrogen governs calmness and coolness.
* Inevitable Cessation: Because life is an integrated, multi-elemental feedback loop, the complete, irreversible loss of even a single CHON element instantly collapses the homeostatic matrix. Without the active presence and interaction of all four elements, biological organization cannot be sustained, confirming the absolute boundary of life.

From the perspective of CHON Balancing Mitotherapy (CBM), Polycystic O***y Syndrome (PCOS) can be interpreted as a metab...
06/08/2026

From the perspective of CHON Balancing Mitotherapy (CBM), Polycystic O***y Syndrome (PCOS) can be interpreted as a metabolic regulatory disorder rather than solely a gynecological disease. The following is a CBM conceptual framework and should be considered a hypothesis rather than an established medical model.

CBM View of PCOS as a Metabolic Disorder

1. Primary Disturbance

CBM interprets PCOS as a chronic imbalance between anabolic (building) and catabolic (energy-consuming) regulation.

Hydrogen (H): ↑ Increased storage, moisture, adiposity, insulin excess

Carbon (C): ↑ Tissue accumulation, ovarian stromal thickening, cyst formation

Oxygen (O): ↓ Reduced mitochondrial energy utilization and ovulation efficiency

Nitrogen (N): ↓ Impaired regulatory balance and endocrine homeostasis

2. Metabolic Changes

According to this CBM interpretation:

Insulin resistance favors Hydrogen dominance.

Excess insulin promotes ovarian androgen production.

Reduced mitochondrial efficiency lowers Oxygenic metabolism.

Carbon accumulation contributes to multiple immature follicles that fail to ovulate.

3. Ovarian Changes

Failure of normal follicular maturation

Anovulation

Multiple small follicles ("polycystic" appearance)

Thickened ovarian capsule and stroma

Hormonal imbalance

4. Common Clinical Features

Irregular or absent menstrual periods

Infertility due to anovulation

Weight gain

Central obesity

Acne

Hirsutism

Insulin resistance

Increased risk of type 2 diabetes and metabolic syndrome

5. CBM Therapeutic Goal (Conceptual)

The CBM objective would be to restore elemental balance by:

Reducing excessive Hydrogen–Carbon dominance

Improving Oxygen-dependent mitochondrial energy production

Restoring Nitrogen-mediated regulatory balance

Improving insulin sensitivity

Supporting normal ovulation and endocrine homeostasis

6. Lifestyle Measures Consistent with Current Medical Care

Regardless of the theoretical framework, evidence-based management of PCOS includes:

Weight reduction when overweight

Regular physical activity

Limiting refined sugars and ultra-processed carbohydrates

Eating a high-fiber, balanced diet

Adequate sleep

Stress reduction

Medical evaluation for insulin resistance, diabetes, lipid disorders, and fertility concerns

CBM Summary

Aspect CBM Interpretation

Nature Metabolic–endocrine imbalance
Dominant pattern ↑ Hydrogen + ↑ Carbon
Deficient pattern ↓ Oxygen + ↓ Nitrogen
Result Insulin resistance, anovulation, ovarian cyst formation, androgen excess
Therapeutic aim Restore CHON balance and metabolic homeostasis

This CBM interpretation is distinct from mainstream medical understanding. Current evidence-based medicine explains PCOS through complex interactions among genetics, insulin resistance, ovarian hormone regulation, and environmental factors, while the CHON mapping above represents a conceptual model specific to CBM rather than an established scientific consensus.

Address

Al Riaz Plaza Alhabib Bank Basement Khanna Pull Rawalpindi
Rawalpindi West Ridge
44080

Opening Hours

Monday 10:00 - 15:00
Tuesday 10:00 - 15:00
Wednesday 10:00 - 15:00
Thursday 10:00 - 15:00
Friday 10:00 - 15:00
Saturday 10:00 - 15:00
Sunday 10:00 - 17:00

Telephone

+923145803897

Alerts

Be the first to know and let us send you an email when Dr Nisar Ahmed Ph.D NeuroVascular Specialist posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr Nisar Ahmed Ph.D NeuroVascular Specialist:

Shortcuts

Share